Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
To be added to the distribution list, please email: DDeCastro@southlakeregional.org
In this episode, Dr. Philip Kuruvilla takes us through the Implementation of Bispecific Antibody therapies into a community setting, focusing on management of toxicities of interest specifically Cytokine Release Syndrome (CRS) and Immune Cell Associated Neurotoxicity Syndrome (ICANS).
Key Opinion Leader: Philip Kuruvilla, MD. Assistant Clinical Professor (Adjunct) McMaster University Medical Oncologist Interim Division Chief Hematology - William Osler Health System
Host: Shaqil Kassam MD. MSc. FRCPC skassam@southlakeregional.org Medical Oncologist Stronach Regional Cancer Centre, Newmarket, Ontario
Previous episodes: https://www.blogtalkradio.com/medoncnow
